Skip to main content
[Preprint]. 2023 Aug 21:rs.3.rs-3267009. [Version 1] doi: 10.21203/rs.3.rs-3267009/v1

Figure 1.

Figure 1

A) Representative staining of primary and recurrent tumors for p16, p53 and high risk HPV E6/E7 mRNA. B) Changes in p16 status between primary and recurrent tumors.